Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations.
about
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Panobinostat acts synergistica ...... lls with MyD88 L265 mutations.
@en
Panobinostat acts synergistica ...... lls with MyD88 L265 mutations.
@nl
type
label
Panobinostat acts synergistica ...... lls with MyD88 L265 mutations.
@en
Panobinostat acts synergistica ...... lls with MyD88 L265 mutations.
@nl
prefLabel
Panobinostat acts synergistica ...... lls with MyD88 L265 mutations.
@en
Panobinostat acts synergistica ...... lls with MyD88 L265 mutations.
@nl
P2093
P2860
P1433
P1476
Panobinostat acts synergistica ...... lls with MyD88 L265P mutations
@en
P2093
Aaron Y Chang
Anas Younes
David A Scheinberg
Elisa De Stanchina
Eneda Toska
Hans-Guido Wendel
José Baselga
Myles Fennell
Patrizia Mondello
Ralph Garippa
P2860
P304
P356
10.1172/JCI.INSIGHT.90196
P577
2017-03-23T00:00:00Z